Rebound of COVID-19 Symptoms Rare After Nirmatrelvir/Ritonavir Treatment
Only 0.8 percent of 483 patients with mild-to-moderate SARS-CoV-2 at high risk for severe disease progression had rebound
COVID19
Fauci Tests Positive for COVID-19, Has Mild Symptoms
The infectious disease specialist is fully vaccinated and has received two booster shots
MPR Weekly Dose Podcast #120
FDA panel vote on COVID-19 vaccines for young children; new drug approved to treat alopecia; Paxlovid tested in standard risk individuals.
COVID-19 Vaccines Cut Mortality With Heart Failure
Those who are partially vaccinated and unvaccinated face same increased risk, while boosted and fully vaccinated adults fare best
FDA Panel in Favor of COVID-19 Vaccines for Kids as Young as 6 Months
According to the CDC, as of June 7, 2022, there have been over 13.1 million cases of COVID-19 among children and adolescents 0 to 17 years of age.
Mixed Results for Paxlovid in Standard Risk Patients With COVID-19
The study evaluated Paxlovid in both vaccinated and unvaccinated patients with COVID-19 at standard risk for progressing to severe disease.
Millions of COVID-19 Shots Ready for Children Under 5: White House
Children under 5 are the only age group in the United States not yet eligible for COVID-19 shots
Two New Omicron Subvariants Gain Ground in the US
Subvariants now account for 13 percent of new coronavirus cases nationwide compared with 7.5 percent a week ago
WHO Experts Open to Notion That China Lab Leak Spurred COVID-19
Agency noted that lab accidents have triggered some previous outbreaks, so theory could not be discounted
MPR Weekly Dose Podcast #119
The FDA Advisory Committee vote on Novavax; new option for MMR vaccination; Dupixent approval expanded; and we take a look at the latest data on COVID-19 treatments.
